A detailed history of Crestline Management, LP transactions in Astrazeneca PLC stock. As of the latest transaction made, Crestline Management, LP holds 37,335 shares of AZN stock, worth $2.79 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
37,335
Previous 61,269 39.06%
Holding current value
$2.79 Million
Previous $4.77 Million 48.76%
% of portfolio
0.08%
Previous 0.25%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

SELL
$63.2 - $79.58 $1.51 Million - $1.9 Million
-23,934 Reduced 39.06%
37,335 $2.45 Million
Q3 2024

Nov 13, 2024

BUY
$76.67 - $87.62 $4.7 Million - $5.37 Million
61,269 New
61,269 $4.77 Million
Q3 2018

Nov 14, 2018

SELL
$34.76 - $39.72 $5.36 Million - $6.13 Million
-154,290 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$34.55 - $37.05 $3.05 Million - $3.28 Million
88,422 Added 134.24%
154,290 $5.42 Million
Q1 2018

May 15, 2018

BUY
$32.97 - $36.63 $2.17 Million - $2.41 Million
65,868 New
65,868 $2.3 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $232B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Crestline Management, LP Portfolio

Follow Crestline Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crestline Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Crestline Management, LP with notifications on news.